Hesheng Luo
- Cancer Research top 5%
- MicroRNA in disease regulation 11
- Cancer-related molecular mechanisms research 9
- Molecular Biology top 10%
- RNA modifications and cancer 5
- Circular RNAs in diseases 5
- Oncology top 10%
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects 7
- Hepatology top 10%
- Liver physiology and pathology 6
-
- Liver Disease Diagnosis and Treatment 7
-
- Gastrointestinal disorders and treatments 4
- Co-authors
- Jie‐Ping YuTao DengHonggang YuYaowei AiXiang DingYu ZhouShiquan LiuPing An
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Hesheng Luo
62 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 103
- Cancer Research 561
- Molecular Biology 1.0k
- Oncology 398
- Pharmacology 117
- Hepatology 86
Countries citing papers authored by Hesheng Luo
This map shows the geographic impact of Hesheng Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hesheng Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hesheng Luo more than expected).
Fields of papers citing papers by Hesheng Luo
This network shows the impact of papers produced by Hesheng Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hesheng Luo. The network helps show where Hesheng Luo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hesheng Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 8 | |
| 2 | 2020 | 14 | |
| 3 | 2020 | 62 | |
| 4 | 2018 | 9 | |
| 5 | 2017 | 42 | |
| 6 | 2017 | 39 | |
| 7 | 2016 | 59 | |
| 8 | [Association between patatin-like phospholipase domain-containing protein 3 gene rs738409 polymorphism and non-alcoholic fatty liver disease susceptibility: a meta-analysis]. | 2015 | 1 |
| 9 | Association between cytotoxic T-lymphocyte antigen-4 +49A/G polymorphism and colorectal cancer risk: a meta-analysis. | 2015 | 10 |
| 10 | 2014 | 42 | |
| 11 | 2013 | 59 | |
| 12 | 2012 | 55 | |
| 13 | 2009 | 56 | |
| 14 | 2009 | 35 | |
| 15 | 2007 | 177 | |
| 16 | 2006 | 28 | |
| 17 | 2006 | 21 | |
| 18 | 2004 | 3 | |
| 19 | 2003 | 34 | |
| 20 | 2002 | 67 |
About Hesheng Luo
Hesheng Luo is a scholar working on Cancer Research, Gastroenterology and Hepatology, having authored 62 papers that have together received 1.8k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (9 papers), Liver Disease Diagnosis and Treatment (7 papers), Inflammatory mediators and NSAID effects (7 papers), Liver physiology and pathology (6 papers), RNA modifications and cancer (5 papers), Circular RNAs in diseases (5 papers) and Gastrointestinal disorders and treatments (4 papers). The work is most often cited by research in Cancer Research (561 citations), Molecular Biology (1.0k citations) and Oncology (398 citations). Hesheng Luo has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Jie‐Ping Yu, Tao Deng, Honggang Yu, Yaowei Ai, Xiang Ding, Yu Zhou, Shiquan Liu, Ping An, Shicai Ye and Xiao Feng.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.